6RKF
Structure of human DASPO
6RKF の概要
| エントリーDOI | 10.2210/pdb6rkf/pdb |
| 分子名称 | D-aspartate oxidase, FLAVIN-ADENINE DINUCLEOTIDE, GLYCEROL, ... (6 entities in total) |
| 機能のキーワード | d-aspartate oxidase, d-aspartate, flavoprotein, oxidase, daspo, hdaspo, ddo, hddo oxidoreductase, fad |
| 由来する生物種 | Homo sapiens (Human) |
| タンパク質・核酸の鎖数 | 6 |
| 化学式量合計 | 238106.49 |
| 構造登録者 | |
| 主引用文献 | Molla, G.,Chaves-Sanjuan, A.,Savinelli, A.,Nardini, M.,Pollegioni, L. Structure and kinetic properties of human d-aspartate oxidase, the enzyme-controlling d-aspartate levels in brain. Faseb J., 34:1182-1197, 2020 Cited by PubMed Abstract: d-Amino acids are the "wrong" enantiomers of amino acids as they are not used in proteins synthesis but evolved in selected functions. On this side, d-aspartate (d-Asp) plays several significant roles in mammals, especially as an agonist of N-methyl-d-aspartate receptors (NMDAR), and is involved in relevant diseases, such as schizophrenia and Alzheimer's disease. In vivo modulation of d-Asp levels represents an intriguing task to cope with such pathological states. As little is known about d-Asp synthesis, the only option for modulating the levels is via degradation, which is due to the flavoenzyme d-aspartate oxidase (DASPO). Here we present the first three-dimensional structure of a DASPO enzyme (from human) which belongs to the d-amino acid oxidase family. Notably, human DASPO differs from human d-amino acid oxidase (attributed to d-serine degradation, the main coagonist of NMDAR) showing peculiar structural features (a specific active site charge distribution), oligomeric state and kinetic mechanism, and a higher FAD affinity and activity. These results provide useful insights into the structure-function relationships of human DASPO: modulating its activity represents now a feasible novel therapeutic target. PubMed: 31914658DOI: 10.1096/fj.201901703R 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (3.219 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






